DexCom Inc (BSP:D1EX34)
R$ 9.65 0 (0%) Market Cap: 188.46 Bil Enterprise Value: 189.05 Bil PE Ratio: 47.26 PB Ratio: 15.58 GF Score: 74/100

Dexcom Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 14, 2022 / 12:30PM GMT
Release Date Price: R$9.29 (-0.11%)
Jeffrey D. Johnson
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

All right. Good morning. Why don't we get started? My name is Jeff Johnson. I'm the senior medical technology analyst at Baird, and our next presentation this morning is from DexCom, a leading manufacturer of continuous glucose monitors used for diabetes care.

With us today from DexCom, we're happy to have CFO, Jereme Sylvain, and newly promoted, congratulations on that, Jake Leach, Chief Operating Officer. Jereme, I'll turn it over to you if you have a couple of minutes of anything you want to say from a prepared standpoint, and then we'll just go straight into Q&A.

Jereme M. Sylvain
DexCom, Inc. - Executive VP, CFO & CAO

No, look, we're happy everybody is here. We love talking about this. I think when you think about our company and the unmet need in the space, it remains to be incredibly large. And the future is bright with both our current product portfolio as well as those that are coming here in the near future. So incredibly bullish.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot